12.07.2015 Views

marker-assisted selection in wheat - ictsd

marker-assisted selection in wheat - ictsd

marker-assisted selection in wheat - ictsd

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

408Marker-<strong>assisted</strong> <strong>selection</strong> – Current status and future perspectives <strong>in</strong> crops, livestock, forestry and fishbalance between private rights and the needsof society (Murchie et al., 2006). Society ispresumed to benefit from public disclosure<strong>in</strong> the form of patent disclosure requirementsand copyrights, which are awardedto creative works that have been fixed (madetangible). In addition, through the comb<strong>in</strong>ationof the requirement of full disclosure<strong>in</strong> the written description (manifested <strong>in</strong> apatent application), and the time limitationover patents rights, <strong>in</strong>ventions are put <strong>in</strong>tothe public doma<strong>in</strong> when the rights expire.The pharmaceutical <strong>in</strong>dustry’s experiencewith the success of “generics” is a testamentto the value of “expired” <strong>in</strong>ventions (CBO,1998). In some specific cases, however, suchas patents on certa<strong>in</strong> drugs, rights may beextended for a certa<strong>in</strong> period of time uponrequest to compensate for long delays <strong>in</strong>obta<strong>in</strong><strong>in</strong>g authorization for drug commercialization,e.g. the “Hatch-Waxman” act<strong>in</strong> the United States of America. The fil<strong>in</strong>g,prosecut<strong>in</strong>g and ma<strong>in</strong>tenance of patents arebus<strong>in</strong>ess decisions that are put <strong>in</strong>to placeas a part of the strategy for br<strong>in</strong>g<strong>in</strong>g productsto the consumer. An additional partof such a strategy can also <strong>in</strong>clude a planfor ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g profitability when patentrights expire (Smyth, 2006). For example,depend<strong>in</strong>g upon the creativity of <strong>in</strong>ventors,it may be that improvements allowfor the fil<strong>in</strong>g of additional patents to coverthese improvements, thus hav<strong>in</strong>g the effectof extend<strong>in</strong>g patent rights for additionalterms. This is a fact-based process, <strong>in</strong> thatthe improvement must meet the requirementsof <strong>in</strong>vention. Not that efficient and s<strong>in</strong>cere disclosure is notwithout problems – see Fromer (2007).Note that concerns regard<strong>in</strong>g the abuse of thepatent<strong>in</strong>g of <strong>in</strong>cremental changes versus <strong>in</strong>crementalimprovements are often raised by a practice of patenttime extension called “evergreen<strong>in</strong>g”. For furtherdiscussion of evergreen<strong>in</strong>g from the view of genericpharmaceutical manufacturers, see Hore (2004).The balance between public and privaterights is considered by some to be tilted<strong>in</strong> favour of private rights, leav<strong>in</strong>g elementsof some societies wonder<strong>in</strong>g if IPRsystems work at all except to protect themonopolies that they award (Epp, 2004).A number of civil society organizations aremonitor<strong>in</strong>g the potential effect of chang<strong>in</strong>gIndia’s patent law to <strong>in</strong>clude patents overpharmaceutical products and agriculturalchemicals (Sreedharan, 2007).Intellectual property law as itrelates to MASThe standard steps employed <strong>in</strong> MASgenerally <strong>in</strong>clude: select<strong>in</strong>g <strong>in</strong>dividuals tobe tested; harvest<strong>in</strong>g material; extractionof DNA from the material; polymerasecha<strong>in</strong> reaction (PCR) amplification of theDNA to enrich for gene sequences/fragmentsassociated with a particular trait orphenotype; separation of these fragments;visualization/identification of DNA fragments;and <strong>in</strong>terpretation and utilizationof the <strong>in</strong>formation. Each of these stages<strong>in</strong>volves certa<strong>in</strong> methods and the use ofparticular reagents and/or equipment associatedwith the particular methodologicalsteps. For the purposes of this chapter, aseries of tables (numbers 1–3) has been preparedto exemplify the types of <strong>in</strong>tellectualproperty and associated IPRs that exist formaterials and/or processes with<strong>in</strong> each ofthese seven steps.There is a general set of categories ofIPRs that are awarded <strong>in</strong> most countries/jurisdictions. These <strong>in</strong>clude <strong>in</strong>dustrial orutility patent rights, plant variety protection/plantbreeders’ rights, copyrights,rights of appellation/geographic <strong>in</strong>dications,trademarks and secrecy rights (tradesecrets) associated with undisclosed or confidential<strong>in</strong>formation. Other types of patentrights can be awarded <strong>in</strong> many jurisdictions.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!